Spring 2021 Newsletter
Spring 2021 Newsletter
A Note from the President
On February 6th, 2021, I was 51 years, 5 months, and 14 days old. “Why is this important?” you ask.
The answer is family. That was the exact same age my dad was when he died back in 2002. In memory of his death, my wife and I set off to Alaska and ventured into the Arctic Circle. The temperature most days was in the negative 30s, with the coldest day coming in at minus 53 degrees Fahrenheit in a small settlement called Coldfoot. (And when I say small, I mean small. Their population is 12 this year.) The cold definitely hurts when it is that frigid out, but the purpose of this trip was to chase the Northern Lights and we certainly got the show I was hoping for. Check out some of our photos above!
The other reason I share this personal note with you is that I have always tried to treat everyone I meet like family. If you’re reading this, at some point we had a connection – whether it be as a client, a contact, a professional service provider, or a friend. TransPharm’s success has been built upon those relationships and 13 years after founding this company, I believe it’s still our greatest strength. Our team is the strongest and most consistent crew we have had since I opened the doors and we are truly a family. So, if you haven’t needed us in a while, now is a great time to get back on board.
The big picture looks very promising around here and we are excited to see what the rest of 2021 will bring. I truly hope all of you stay safe and most importantly, reach out to family if you haven’t done so in a while.
President & CEO
In the Lab
In Vitro and Preliminary Surface Disinfectant Testing
TransPharm has noticed a sharp increase in the number of requests we receive for in vitro testing. We have worked with several new bacterial, viral, and fungal strains. Further, we are currently performing preliminary testing of surface disinfectants. Our scientists have tested novel liquid- and gel-based formulations on a variety of surfaces such as metal, paper, and plastic to determine their efficacy as antimicrobial products. Endpoints include the percentage of microorganisms killed and the length of contact time required to achieve a set percentage. Although our laboratory is not ISO-certified, we use ISO standards to ensure the quality of our results.
Santiago R. Lopez, Ph.D.
Chief Scientific Officer
Upcoming AAALAC Inspection
In addition to complying with local, state, and federal regulations on animal research, TransPharm is proud to be accredited by the American Association for Accreditation of Laboratory Animal Care (AAALAC). AAALAC is a private, non-profit organization that promotes the humane treatment of animals in science through voluntary accreditation and assessment programs. Every three years, our facility undergoes a thorough inspection to ensure that we are not only meeting the minimum standards required by law, but also going above and beyond to achieve excellence in animal care and well-being. We passed our 2018 inspection with flying colors and are looking forward to renewing our accreditation with an upcoming inspection in May. Many advancements in medicine and science would not be possible without animal research, and TransPharm is committed to making this progress in a responsible and ethical way.